OPUS GENETICS INC. -
不适用
31-十二月-69 19:00:00
15 分钟延时
股票
不适用
今日范围
不适用 - 不适用
ISIN
N/A
来源
NASDAQ
-
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update
12 11月 2024 08:00:02 条件 Nasdaq GlobeNewswire
-
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 11月 2024 07:59:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Acquisition of Opus Genetics
22 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
05 9月 2024 20:43:59 条件 Nasdaq GlobeNewswire
-
05 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
13 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Two Investor Conferences in August
08 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
06 6月 2024 07:57:22 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 07:14:52 条件 Nasdaq GlobeNewswire
-
08 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 2月 2024 16:10:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >